- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03646032
Sexually Active Adolescent Focused Education (SAAFE)
December 12, 2019 updated by: Tony Ma, Benten Technologies, Inc.
An mHealth Education Intervention for Encouraging STI Testing Uptake
SAAFE will be pilot tested in 2 geographically distinct areas (Washington, DC and Deep South) with 100 participants from each site to 1) primarily assess the efficacy of improved self-efficacy, knowledge about HIV/STIs and perception of sexual risks by AAAs, and (2) secondarily detect intention to be tested for STIs and to change sexual risk behavior (i.e., use a condom).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A total of 200 African American adolescents (AAA) males and females will be recruited from Washington, DC (n=100) and Birmingham, Alabama (n=100). At both data collection sites, participants will be randomly assigned to one of two groups during the pilot. The two groups are:
- Intervention group (n=100) - will consist of 50 AAA males / 50 AAA females randomly selected participants who will receive a download of the SAAFE game and play for at least 30 minutes and as long as an hour, if desired.
- Control group (n=100) - will consist of 50 AAA males / 50 AAA females randomly selected participants. This group will receive dating sim game (called Choices). They will also receive pamphlets that provide information on the testing location and care if they have HIV/STI.
Study Type
Interventional
Enrollment (Actual)
178
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- The University of Alabama at Birmingham
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Medstar Washington Hospital Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 21 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- African American female or male
- Between 15-21 years of age
Exclusion Criteria:
- Pregnant women
- The first 6 weeks post-partum
- Adolescents younger than 15
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Intervention group (n=200) - will consist of 100 AAA males / 100 AAA females randomly selected participants who will receive a download of the SAAFE game and play for at least 30 minutes and as long as an hour, if desired.
|
After completing the pre-game assessment, participants will be asked to play the SAAFE game for at least 30 minutes and up to 1 hour .
At the conclusion of the game, participants will be provided with a post-game assessment about their perception of risk, knowledge of specific protective behaviors, and whether they plan to change behaviors.
|
|
Active Comparator: Control group
Control group (n=200) - will consist of 100 AAA males / 100 AAA females randomly selected participants.
This group will receive the standard of care by launching a mobile app that will play a dating sim game (called Choices).
They will also receive pamphlets that provide information on the testing location and care if they have HIV/STI.
|
This group will receive dating sim game (called Choices).
They will also receive pamphlets that provide information on the testing location and care if they have HIV/STI.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge about HIV/STIs
Time Frame: 1 month
|
During the pilot, adolescents will be asked if they would like to download the game to play on their own mobile device and complete a pre- and post-game assessment designed to measure their knowledge on HIV/STIs by assessing the level of knowledge around risky sexual activity.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perception of sexual risks
Time Frame: 1 month
|
During the pilot, adolescents will be asked if they would like to download the game to play on their own mobile device and complete a pre- and post-game assessment designed to measure their perceived risk
|
1 month
|
|
Intention to be tested for STIs
Time Frame: 1 month
|
We will ask participants on a scale of 1-5 their intent to get tested for HIV and most common STI's.
|
1 month
|
|
Intention to use a condom
Time Frame: 1 month
|
We will ask participants on a scale of 1-5, their intent to use a condom.
|
1 month
|
|
Consent
Time Frame: 1 month
|
We will ask participants on a 4-point Likert scale (strongly agree to strongly disagree)
|
1 month
|
|
System Usability and Acceptability Metrics
Time Frame: 1 month
|
We will ask participants to answer the questions based on their current impressions on the game.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tony Ma, MS, Benten Technologies, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 8, 2019
Primary Completion (Actual)
July 15, 2019
Study Completion (Actual)
July 15, 2019
Study Registration Dates
First Submitted
August 21, 2018
First Submitted That Met QC Criteria
August 22, 2018
First Posted (Actual)
August 24, 2018
Study Record Updates
Last Update Posted (Actual)
December 16, 2019
Last Update Submitted That Met QC Criteria
December 12, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- SAAFE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Risk Behaviors
-
Istanbul University - Cerrahpasa (IUC)CompletedHealth Risk Behaviors | Reproductive Health | Sexual HealthTurkey
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaNot yet recruitingHealth Risk Behaviors
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
University Medicine GreifswaldUniversity Hospital Schleswig-Holstein; Deutsche Krebshilfe e.V., Bonn (Germany) and other collaboratorsCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
University of North Texas Health Science CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHealth Risk Behaviors | Risk Reduction BehaviorUnited States
-
Laura RichardsonCompleted
-
University of CalgaryCanadian Institutes of Health Research (CIHR); British Columbia Farmers' Market...CompletedDiet, Healthy | Health Risk BehaviorsCanada